Manulife (Manufacturers Life Insurance)’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,210
| Closed | -$71.1K | – | 2997 |
|
|
2024
Q1 | $71.1K | Buy |
+1,210
| New | +$71.1K | ﹤0.01% | 2854 |
|
|
2023
Q3 | – | Sell |
-1,475
| Closed | -$99.6K | – | 2988 |
|
|
2023
Q2 | $99.6K | Sell |
1,475
-808
| -35% | -$54.5K | ﹤0.01% | 2849 |
|
|
2023
Q1 | $1.07M | Sell |
2,283
-809
| -26% | -$377K | ﹤0.01% | 1605 |
|
|
2022
Q4 | $1.23M | Buy |
3,092
+1,677
| +119% | +$664K | ﹤0.01% | 1529 |
|
|
2022
Q3 | $460K | Sell |
1,415
-33
| -2% | -$10.7K | ﹤0.01% | 2035 |
|
|
2022
Q2 | $382K | Sell |
1,448
-9
| -0.6% | -$2.38K | ﹤0.01% | 2224 |
|
|
2022
Q1 | $438K | Sell |
1,457
-338
| -19% | -$102K | ﹤0.01% | 2279 |
|
|
2021
Q4 | $633 | Sell |
1,795
-43
| -2% | -$15 | ﹤0.01% | 2112 |
|
|
2021
Q3 | $470K | Sell |
1,838
-112
| -6% | -$28.6K | ﹤0.01% | 2335 |
|
|
2021
Q2 | $1.3M | Buy |
1,950
+46
| +2% | +$30.6K | ﹤0.01% | 1829 |
|
|
2021
Q1 | $1.65M | Sell |
1,904
-116
| -6% | -$101K | ﹤0.01% | 1629 |
|
|
2020
Q4 | $1.87M | Buy |
2,020
+73
| +4% | +$67.7K | ﹤0.01% | 1556 |
|
|
2020
Q3 | $2M | Sell |
1,947
-32
| -2% | -$32.9K | ﹤0.01% | 1423 |
|
|
2020
Q2 | $2.01M | Sell |
1,979
-20
| -1% | -$20.3K | ﹤0.01% | 1398 |
|
|
2020
Q1 | $1.74M | Buy |
1,999
+131
| +7% | +$114K | ﹤0.01% | 1337 |
|
|
2019
Q4 | $2M | Sell |
1,868
-57
| -3% | -$61.1K | ﹤0.01% | 1397 |
|
|
2019
Q3 | $1.82M | Sell |
1,925
-13
| -0.7% | -$12.3K | ﹤0.01% | 1400 |
|
|
2019
Q2 | $2.19M | Sell |
1,938
-53
| -3% | -$59.9K | ﹤0.01% | 1357 |
|
|
2019
Q1 | $2.71M | Sell |
1,991
-70
| -3% | -$95.1K | ﹤0.01% | 1352 |
|
|
2018
Q4 | $2.38M | Buy |
2,061
+118
| +6% | +$136K | ﹤0.01% | 1341 |
|
|
2018
Q3 | $2.95M | Sell |
1,943
-273
| -12% | -$415K | ﹤0.01% | 1366 |
|
|
2018
Q2 | $3.47M | Buy |
2,216
+135
| +6% | +$211K | ﹤0.01% | 1359 |
|
|
2018
Q1 | $2.4M | Sell |
2,081
-47
| -2% | -$54.3K | ﹤0.01% | 1441 |
|
|
2017
Q4 | $2.52M | Buy |
2,128
+115
| +6% | +$136K | ﹤0.01% | 1406 |
|
|
2017
Q3 | $2.71M | Buy |
2,013
+162
| +9% | +$218K | ﹤0.01% | 1347 |
|
|
2017
Q2 | $1.5M | Buy |
1,851
+201
| +12% | +$162K | ﹤0.01% | 1583 |
|
|
2017
Q1 | $1.02M | Buy |
1,650
+193
| +13% | +$119K | ﹤0.01% | 1727 |
|
|
2016
Q4 | $779K | Buy |
1,457
+1
| +0.1% | +$535 | ﹤0.01% | 1803 |
|
|
2016
Q3 | $753K | Buy |
1,456
+3
| +0.2% | +$1.55K | ﹤0.01% | 1810 |
|
|
2016
Q2 | $596K | Buy |
1,453
+158
| +12% | +$64.8K | ﹤0.01% | 1918 |
|
|
2016
Q1 | $667K | Buy |
1,295
+21
| +2% | +$10.8K | ﹤0.01% | 1812 |
|
|
2015
Q4 | $970 | Buy |
1,274
+13
| +1% | +$10 | ﹤0.01% | 1639 |
|
|
2015
Q3 | $691 | Buy |
1,261
+27
| +2% | +$15 | ﹤0.01% | 1797 |
|
|
2015
Q2 | $725 | Buy |
1,234
+993
| +412% | +$583 | ﹤0.01% | 1870 |
|
|
2015
Q1 | $189 | Buy |
241
+151
| +168% | +$118 | ﹤0.01% | 2774 |
|
|
2014
Q4 | $62 | Buy |
+90
| New | +$62 | ﹤0.01% | 3185 |
|